Tucker Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Tucker Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.5M	Hold	1,011,064	–	–	4.32%	6
2026 Q1	$12.6M	Hold	1,011,064	–	–	3.76%	6
2025 Q4	$12.7M	Sell	1,011,064 -100,000	-9%	-$1.14M	3.71%	6
2025 Q3	$11.1M	Hold	1,111,064	–	–	3.35%	7
2025 Q2	$8.99M	Hold	1,111,064	–	–	2.87%	7
2025 Q1	$9.31M	Hold	1,111,064	–	–	3.02%	7
2024 Q4	$8.8M	Hold	1,111,064	–	–	0.94%	11
2024 Q3	$9.24M	Hold	1,111,064	–	–	2.13%	11
2024 Q2	$7.06M	Buy	+1,111,064	New	+$7.05M	1.54%	14

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Tucker Asset Management's AMRX Position: Q2 2026 in Review

Tucker Asset Management held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 1,011,064 shares worth $17.5M. The position accounts for 4.32% of the portfolio, ranked #6.

Tucker Asset Management first reported a position in AMRX in Q2 2024 and has held it in 9 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Tucker Asset Management held 1,011,064 shares of Amneal Pharmaceuticals worth $17.5M as of Q2 2026.
Tucker Asset Management left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
Amneal Pharmaceuticals made up 4.32% of Tucker Asset Management's portfolio in Q2 2026, its #6 holding.
Tucker Asset Management first reported a position in Amneal Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Tucker Asset Management's 13F filing for Q2 2026, filed 27 Aug 2026.